NEW YORK (GenomeWeb News) – PerkinElmer and Verinata Health said this week that "several of the top health insurance plans" now cover Verinata's Verifi non-invasive prenatal diagnostic test. As a result, more than 80 million covered lives have access to the test. PerkinElmer Chairman and CEO Robert Friel said that two of the top-five providers recently signed agreements to cover Verifi, though he did not elaborate. He added that more than 15 health plans now cover Verifi.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.